TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients

Go back to TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 213.58 -7.25 (3.28%)
Previous Close $220.83    52 Week High $333.65 
Open $215.45    52 Week Low $223.02 
Day High $217.28    P/E 27.35 
Day Low $210.54    EPS $7.81 
Volume 119,088